strate specificity by inactivation of the aheB gene and subsequent AheABC complementation experiments.
At first, the transcription of the aheB gene in A. hydrophila ATCC 7966
T (collection of Institut Pasteur, France) was assessed by reverse transcription (RT)-PCR amplification. RNA extracts (2 ng) were prepared from logarithmic and lategrowth-phase cultures in Mueller-Hinton (MH) broth, with an SV Total RNA Isolation kit that includes a DNase treatment (Promega, France). The oligonucleotides used, AheB1F1 and MotifD1 (Table 1) , targeted an internal fragment of aheB (Fig.  1) . RT-PCR experiments were carried out with and without (as control) reverse transcriptase in a single RT-PCR system tube, using an AccessQuick RT-PCR kit and RT-PCR conditions as recommended by the manufacturer (i.e., one RT step of 45°C for 45 min and then 40 cycles of 94°C for 30 s, 60°C for 1 min, and 68°C for 1 min) (Promega). An RT-PCR fragment with the expected size of 947 bp was obtained for cells grown at both growth phases, demonstrating that aheB was constantly transcribed in A. hydrophila ATCC 7966
T (data not shown). Further analysis by Northern blotting and/or quantitative RT-PCR would be necessary to evaluate expression variations at different growth phases, as previously shown for mexB in Pseudomonas aeruginosa (6) .
Since aheB was expressed in cells grown in standard laboratory medium, in contrast to other pumps (13, 16) , its inactivation could be performed to examine the resulting hypersensitive phenotype. Thus, two PCR products with restriction sites at their ends were amplified from the aheB gene, i.e., the amplicon A, using the primer pairs motifAF_KpnI and motifAR_SalI and the amplicon D, using the primer pairs motifDF_BamHI and motifDR_SphI ( Table 1 ). The digested A and D fragments were ligated with the aph3Ј gene (conferring kanamycin resistance [Kan r ]) amplified by the primer pair kan1_SalI and kan2_BamHI from the pTnModOKan plasmid (Table 1 and Fig. 1 ) (4). The resulting AKD fragment was inserted into the KpnI and SphI double-digested plasmid pEX19Gm, generating the pEX-AKD plasmid. This vector was introduced by electroporation into the E. coli strain SM10 (Belgian Coordinated Collections of Microorganisms, Belgium), which is able to trans mobilize plasmids containing an oriT transfer origin, such as pEX19Gm (10) . Conjugation experiments between the recombinant E. coli SM10 as the donor strain and A. hydrophila (intrinsically ampicillin resistant) as the recipient strain were performed by using a filter-mating procedure (3) . A. hydrophila transconjugants were obtained on selective MH agar medium supplemented with kanamycin (50 mg/liter) plus ampicillin (100 mg/liter) at a transfer frequency of ca. 10 Ϫ5 per donor cell. However, it was found that the plasmids PEX19Gm and pEX-AKD were able to replicate in A. hydrophila, in contrast to those in P. aeruginosa (10) (data not shown). Then, aheB was inactivated by using the sacB-based strategy: the sacB gene located on pEX19Gm and pEX-AKD codes for a levansucrase that yields toxic metabolites at high sucrose concentrations (10). Accordingly, after growth on a selective medium containing a 10% lethal concentration of sucrose, one of the survivors, the ⌬aheB::kan mutant, was selected. PCR amplification experiments, followed by sequencing, revealed that the kanamycin cassette was correctly inserted in chromosomal DNA at amino acid position 220 of AheB, leading to the deletion of amino acids 221 to 361 (data not shown).
To outline the substrate specificity of the AheABC efflux pump, complementation experiments were necessary. Despite several independent experiments, cloning a PCR product of the entire aheABC operon directly into pEX19Gm remained unsuccessful. Thus, we performed a previous cloning step with Saccharomyces cerevisiae. First, using a Phusion DNA polymerase (Finnzymes, Finland), the operon was amplified with the primer pair yAheAdbt and yAheCfnR (Table 1) (Fig. 1) . The resulting fragment of 5,769 bp contained XbaI and EcoRI recognition restriction sites and an usual prokaryotic ribosome binding site (GGAGG) 6 bp upstream from the ATG initiation codon (Table 1) . This fragment was mixed with the linearized yeast-bacteria shuttle vector pGB6 (an unpublished vector derived from pRS316, including URA3, encoding a uracil biosynthesis enzyme, and bla TEM-1 , encoding ampicillin resistance). Cells of S. cerevisiae BY4742 (ura3⌬0; EUROpean S. cerevisiae ARchive for Functional collection, Germany) were transformed with the aheABC fragment and the pGB6 plasmid according to a one-step protocol based on an incubation of 30 min at 45°C in a medium containing thio compounds and alkali ions (2) . The presence of the same 20-bp sequence at the ends of the amplicon (Table 1 , primers yAheAdbt and yAheCfnR) and at the ends of the linearized vector allowed an efficient homologous recombination in yeast and led to the formation of the replicative circular plasmid pGB-AheABC. Yeast plasmids were extracted from the uracil-positive clones by a previously described procedure (19) , and one of them was transferred by electroporation to E. coli SM10. After double digestion with XbaI and EcoRI, the insert of pGB-AheABC was introduced into pEX19Gm in the same orientation as the resident lacZ promoter for optimal expression, generating the pEX-Ahe-ABC plasmid. After verification by sequencing, this recombinant plasmid, which conferred gentamicin resistance due to the presence of an aacC1 determinant located on pEX19Gm was transferred by conjugation to the ⌬aheB::kan mutant. Thus, Aeromonas transconjugants were selected and cultivated on an MH medium containing ampicillin (100 mg/liter) and gentamicin (10 mg/liter).
Aeromonas strains with native or recombinant plasmids were compared first by the agar diffusion method, using all 53 available antibiotic disks (amikacin, amoxicillin, amoxicillin-clavulanic acid, ampicillin, aztreonam, cefepime, cefoperazone, cefotaxime, cefotetan, cefoxitin, cefpirome, cefsulodin, ceftazidime, cefuroxime, cephalothin, chloramphenicol, ciprofloxacin, clindamycin, colistin, doxycycline, erythromycin, fosfomycin, fusidic acid, gentamicin, imipenem, levofloxacin, lincomycin, minocycline, moxalactam, nalidixic acid, netilmicin, nitrofurantoin, nitroxolin, norfloxacin, ofloxacin, oxacillin, penicillin, pipemidic acid, piperacillin, piperacillin-tazobactam, pristinamycin, rifampin, sparfloxacin, spectinomycin, spiramycin, streptomycin, sulfamethoxazole, tetracycline, ticarcillin, ticarcillin-clavulanic acid, tobramycin, trimethoprim, and trimethoprim-sulfamethoxazole; Bio-Rad, France), corresponding to drugs currently in use for the treatment of human infections (15) . Then, MICs were determined by an agar dilution method in MH medium, with a final inoculum of about 10 4 CFU per spot (15) , for the nine compounds that showed variations (cefuroxime, cefoperazone, erythromycin, lincomycin, pristinamycin, minocycline, trimethoprim, fusidic acid, and rifampin). The MICs of 10 nonantibiotic agents were also determined. Four of them gave varied results (ethidium bromide, acridine orange, benzalkonium chloride, and tributyltin), while six gave no changes (sodium dodecyl sulfate, rhodamine 6G, crystal violet, sodium deoxycholate, tetraphenylphosphonium chloride, and acriflavine) ( Table 2 ). The differences in MICs between the wild-type A. hydrophila strain and its hypersensitive mutant did not exceed fourfold, suggesting that AheB expres- (23) . Alternatively, these low MIC differences might be ascribed to the overproduction of other efflux pumps or a regulatory system(s) in A. hydrophila to compensate the nonfunctional AheB protein, as described for AcrB mutations in Salmonella enterica serovar Typhimurium (5) . When the multicopy pEX-AheABC plasmid was introduced into the ⌬aheB::kan mutant, the same compounds were affected, but differences in MICs were often higher, reaching 33-fold for cefoperazone and 16-fold for cefuroxime, pristinamycin, and tributyltin, and thus were considered the preferential substrates of AheB (Table 2) . In order to compare the substrate profiles of AheABC and AcrAB, pEX-AheABC was introduced into E. coli TG1⌬acrAB (17) . AheABC retained its substrate specificity in this heterologous host, except for rifampin and trimethoprim, which were not affected. The increases in MICs of some substrates (acridine orange and tributyltin) were lower in E. coli than in A. hydrophila strains, whereas the reverse was noted for other drugs (erythromycin, fusidic acid, and ethidium bromide). Consequently, these variations did not seem to be related to different levels of AheABC expression in both bacteria but rather resulted from differences in outer-membrane permeability, as previously suggested for MexAB-OprM in E. coli and P. aeruginosa (22) . MIC variations for the two E. coli isogenic ⌬acrAB and ⌬acrAB(pUCAcrAB) strains (17) were higher than those for the ⌬acrAB and ⌬acrAB(pEXAheABC) strains for all AheABC substrates except pristinamycin and trimethoprim (Table 2) . Thus, even if both RND pumps share sequence homologies, AheABC appears to have a narrower range of substrates than AcrAB-TolC (23) . Indeed, in contrast to the latter pump, AheABC did not extrude acriflavine and quinolones, although RND family exporters are commonly involved in fluoroquinolone resistance in gram-negative bacteria (18) . Similarly, AheABC did not accommodate bile salts, due maybe to the fact that the usual environment of this bacteria is not, as for E. coli, the human digestive tract (1). In contrast, AcrAB exported tributyltin much more efficiently than AheABC did, although this antifouling agent is a common pollutant of water sediments that can occasionally contaminate the Aeromonas sp. ecosystem (12) .
The addition of PA␤N (Sigma-Aldrich, France) (14) did not modify the MICs of some AheABC substrates (cefuroxime, cefoperazone, lincomycin, ethidium bromide, and benzalkonium chloride), whereas it strongly decreased the MICs of others, whether they were preferential substrates of this pump or not ( Table 2 ). The considerable potentiation of some compounds by PA␤N in the wild-type A. hydrophila strain as well as in its ⌬aheB::kan mutant suggested that this inhibitor might block an additional RND efflux system(s).
In conclusion, this report is the first functional analysis of a multidrug efflux pump belonging to the RND family in Aeromonas spp. The AheABC system is involved in the MDR phenotype of A. hydrophila, albeit at low levels. However, inhibition tests using PA␤N indicate that other RND-type efflux pumps also contribute to the intrinsic drug resistance of this species. Further experiments, facilitated by the methodology developed in this work, are warranted to explore the type of transport, substrate profile, and regulation mechanisms of these systems.
Nucleotide sequence accession number. The nucleotide sequence of the 6,554-bp fragment containing the aheRABC genes of A. hydrophila ATCC 7966
T has been deposited in the GenBank/EMBL sequence database under accession number EF613320.
